Microarray testing in patients with systemic lupus erythematosus identifies a high prevalence of CpG DNA-binding antibodies
Guardado en:
Autores principales: | Jacob M van Laar, Linda Mathsson-Alm, Tammo Brunekreef, Jorge Dias, Henny Otten, Saskia Haitjema, Imo Hoefer, Rowena Melchers |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0db1c67062fe4be682b696b4d37edd80 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An antibody-based leukocyte-capture microarray for the diagnosis of systemic lupus erythematosus.
por: Ming-Wei Lin, et al.
Publicado: (2013) -
Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.
por: Ken Kron, et al.
Publicado: (2009) -
Low biological fluctuation of mitochondrial CpG and non-CpG methylation at the single-molecule level
por: Chloe Goldsmith, et al.
Publicado: (2021) -
CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen W, et al.
Publicado: (2021) -
Moulage: "Lupus Erythematosus"
por: Beatrix Patzak
Publicado: (2011)